Literature DB >> 18205253

Occult sporadic insulinoma: localization and surgical strategy.

Bassam Abboud1, Joe Boujaoude.   

Abstract

Insulinomas continue to pose a diagnostic challenge to physicians, surgeons and radiologists alike. Most are intrapancreatic, benign and solitary. Biochemical diagnosis is obtained and imaging techniques to localize lesions continue to evolve. Surgical resection is the treatment of choice. Despite all efforts, an occult insulinoma (occult insulinoma refers to a biochemically proven tumor with indeterminate anatomical site before operation) may still be encountered. New localization preoperative techniques decreases occult cases and the knowledge of the site of the mass before surgery allows to determine whether enucleation of the tumor or pancreatic resection is likely to be required and whether the tumor is amenable to removal via a laparoscopic approach. In absence of preoperative localization and intraoperative detection of an insulinoma, blind pancreatic resection is not recommended.

Entities:  

Mesh:

Year:  2008        PMID: 18205253      PMCID: PMC2683990          DOI: 10.3748/wjg.14.657

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  129 in total

1.  The prolonged fast.

Authors:  F J Service; N Natt
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

2.  The role of intra-arterial calcium stimulation test with hepatic venous sampling (IACS) in the management of occult insulinomas.

Authors:  Ling-Ming Tseng; Jui-Yu Chen; Justin Ging-Shing Won; Hsiao-Shan Tseng; An-Han Yang; Sine-E Wang; Chen-Hsen Lee
Journal:  Ann Surg Oncol       Date:  2007-04-12       Impact factor: 5.344

3.  Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas.

Authors:  M A Anderson; S Carpenter; N W Thompson; T T Nostrant; G H Elta; J M Scheiman
Journal:  Am J Gastroenterol       Date:  2000-09       Impact factor: 10.864

4.  Intra-operative quick insulin assay to confirm complete resection of insulinomas guided by selective arterial calcium injection (SACI).

Authors:  Oliver Gimm; Evelyn König; Phuong Nguyen Thanh; Michael Brauckhoff; Wolfram Karges; Henning Dralle
Journal:  Langenbecks Arch Surg       Date:  2007-02-09       Impact factor: 3.445

Review 5.  Gastrointestinal neuroendocrine tumors.

Authors:  R Delcore; S R Friesen
Journal:  J Am Coll Surg       Date:  1994-02       Impact factor: 6.113

6.  Preoperative diagnosis of insulinoma: low body mass index, young age, and female gender are associated with negative imaging by endoscopic ultrasound.

Authors:  P H Kann; D Ivan; A Pfützner; Th Forst; P Langer; S Schaefer
Journal:  Eur J Endocrinol       Date:  2007-08       Impact factor: 6.664

Review 7.  Pancreatic endocrine tumors.

Authors:  Niraj Jani; A James Moser; Asif Khalid
Journal:  Gastroenterol Clin North Am       Date:  2007-06       Impact factor: 3.806

8.  Endoscopic ultrasonography (EUS) in the localization of insulinoma.

Authors:  Rasoul Sotoudehmanesh; Anooshirvan Hedayat; Nahid Shirazian; Shadi Shahraeeni; Sanaz Ainechi; Fatemeh Zeinali; Shadi Kolahdoozan
Journal:  Endocrine       Date:  2007-06       Impact factor: 3.633

9.  Intraoperative doppler ultrasound: a reliable diagnostic method in insulinoma.

Authors:  Hasan Kalafat; Ismail Mihmanli; Kaya Saribeyoglu; Ahmet Belli
Journal:  Hepatogastroenterology       Date:  2007-06

10.  Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.

Authors:  D Vezzosi; A Bennet; J Fauvel; P Caron
Journal:  Eur J Endocrinol       Date:  2007-07       Impact factor: 6.664

View more
  27 in total

1.  Impact of variant pancreatic arterial anatomy and overlap in regional perfusion on the interpretation of selective arterial calcium stimulation with hepatic venous sampling for preoperative localization of occult insulinoma.

Authors:  Scott M Thompson; Adrian Vella; F John Service; Clive S Grant; Geoffrey B Thompson; James C Andrews
Journal:  Surgery       Date:  2015-04-11       Impact factor: 3.982

2.  Metabolic acidosis as a complication of intravenous dextrose administration in a patient with insulinoma.

Authors:  Agustín Ramos-Prol; Maribel del Olmo-García; Antonia Pérez-Lázaro; María Caballero-Soto; María Argente-Pla; Beatriz León-de Zayas; Juan Francisco Merino-Torres
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 3.  The functioning side of the pancreas: a review on insulinomas.

Authors:  I Maggio; V Mollica; N Brighi; G Lamberti; L Manuzzi; A D Ricci; D Campana
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

4.  Intra-arterial calcium stimulation test with hepatic venous sampling for preoperative diagnosis of a large insulinoma in an obese young man.

Authors:  Ya-Cheng Chen; Chang-Hsien Liu; Chih-Yung Yu; Guo-Shu Huang
Journal:  Singapore Med J       Date:  2014-08       Impact factor: 1.858

5.  A case of occult insulinoma localized by pancreatic dynamic enhanced spiral CT.

Authors:  Zhao-Kang Bao; Xin-Yu Huang; Jun-Gong Zhao; Qi Zheng; Xiao-Feng Wang; Hong-Cheng Wang
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

6.  Severe Unresponsive Hypoglycemia Associated with Neuroendocrine Tumor of Unknown Primary Site - 18 Years after Rectal Cancer Surgery. Case Report.

Authors:  Octavia Cristina Rusu; Radu Virgil Costea; Cristian Constantin Popa; Andreea Iliesiu; Adrian Dumitru; Gabriel Becheanu; Stefan Ilie Neagu
Journal:  Maedica (Bucur)       Date:  2015-09

7.  Clinical profile of insulinoma: analysis from a tertiary care referral center in India.

Authors:  Raju A Gopal; Shrikrishna V Acharya; Sunil K Menon; Tushar R Bandgar; Padma S Menon; Nalini S Shah
Journal:  Indian J Gastroenterol       Date:  2010-10-16

8.  68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET.

Authors:  Maarten Brom; Wim J G Oyen; Lieke Joosten; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01-29       Impact factor: 9.236

9.  Insulinoma: rare yet important.

Authors:  Taha Hasan Al-Saigh
Journal:  BMJ Case Rep       Date:  2014-02-27

10.  Identification of CD90 as Putative Cancer Stem Cell Marker and Therapeutic Target in Insulinomas.

Authors:  Floryne O Buishand; Ger J A Arkesteijn; Laurien R Feenstra; Claire W D Oorsprong; Margiet Mestemaker; Achim Starke; Ernst-Jan M Speel; Jolle Kirpensteijn; Jan A Mol
Journal:  Stem Cells Dev       Date:  2016-05-05       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.